Status:
COMPLETED
Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes Mellitus (Type 2)
Lead Sponsor:
Harras Pharma Curarina GmbH
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
45-80 years
Phase:
PHASE3
Brief Summary
In patients with diabetes mellitus type 2 stably adjusted to diet long-term intake of aqueous-ethanolic extract from Hintonia latiflora over more than 12 months leads to a statstically significant ame...
Detailed Description
Objective: To evaluate the long term effects of an aqueous-ethanolic extract from the bark of Hintonia latiflora (1:4.5, extraction medium 32% ethanol) in mild to moderate cases of type II diabetes, ...
Eligibility Criteria
Inclusion
- Mild to moderate Diabetes mellitus type 2 stable adjusted to diet
- Minimum duration of diabetic complaints 1 year
- Fasting serum glucose 7-14 mmol/l
- HbA1c max. 12%
- Written consent
Exclusion
- Hepatic impairment
- Renal impairment
- Pregnancy
Key Trial Info
Start Date :
June 1 2002
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00315718
Start Date
June 1 2002
End Date
June 1 2005
Last Update
April 19 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of Trencin
Trenčín, Slovakia, SK-91171